Klotho plasma levels are an independent predictorof mortality in women with acute coronary syndrome

Abstract Alterations in plasma levels of the components of the mineral metabolism (MM) system are related to cardiovascular diseases. However, gender differences of the whole MM system in patients with acute coronary syndrome (ACS) have not been reported. Our objective was to analyse the potential d...

Full description

Saved in:
Bibliographic Details
Main Authors: Marcelino Cortés, Andrea Kallmeyer, Nieves Tarín, Carmen Cristóbal, Ana María Pello, Alvaro Aceña, Carlos Gutiérrez-Landaluce, Ana Huelmos, Joaquín Alonso, Lorenzo López-Bescós, Ignacio Mahíllo-Fernández, Óscar Lorenzo, María Luisa González-Casaus, Jesús Egido, José Tuñón
Format: Article
Language:English
Published: Nature Portfolio 2025-05-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-01334-2
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Alterations in plasma levels of the components of the mineral metabolism (MM) system are related to cardiovascular diseases. However, gender differences of the whole MM system in patients with acute coronary syndrome (ACS) have not been reported. Our objective was to analyse the potential differences on the prognostic role of MM in women suffering an ACS as compared to men. We included 1,230 patients with ACS and collected clinical data and plasma levels of MM components. Primary outcome was a composite of acute ischaemic events, heart failure and all-cause mortality. Secondary outcomes included each component separately. 282 patients (22.9%) were female. After 5.44 years of follow-up, primary outcome occurred in 28.0% women and 23.5% men, and death in 10.6% and 9.4% respectively. FGF23 was associated with primary outcome in both sexes, and calcidiol only in men (HR 1.04, CI95%1.00-1.03). Klotho levels are inversely related to all-cause mortality only in women (HR 0.80, CI95% 0.67–0.96), while calcidiol (HR 0.84, CI95%0.72–0.98) and FGF23 levels (HR 1.02 CI95%1.00-1.03) were predictors in men, highlighting a possible gender-specific prognostic biomarker. These results underline the importance of considering MM biomarkers in risk stratification and management of patients with acute coronary syndromes, with attention to gender differences.
ISSN:2045-2322